Hemogenyx Pharmaceuticals Plc (HEMO.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,586 | 159 | 1,248 | 2,533 | 6,841 |
| Other current assets | 13 | 8 | 5 | 10 | 8 |
| TOTAL | $2,035 | $839 | $2,170 | $2,595 | $7,139 |
| Non-Current Assets | |||||
| PPE Net | 1,803 | 2,727 | 3,312 | 3,916 | 797 |
| Intangibles | 182 | 477 | 470 | 441 | 441 |
| Other Non-Current Assets | 157 | 168 | 154 | 141 | 143 |
| TOTAL | $2,141 | $3,373 | $3,936 | $4,498 | $1,381 |
| Total Assets | $4,176 | $4,212 | $6,106 | $7,093 | $8,520 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 965 | 683 | 302 | 374 | 296 |
| TOTAL | $1,470 | $1,159 | $652 | $748 | $353 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 51 | 44 | 38 | 32 | 24 |
| TOTAL | $1,562 | $2,199 | $2,673 | $3,101 | $0 |
| Total Liabilities | $3,031 | $3,358 | $3,325 | $3,849 | $353 |
| Shareholders' Equity | |||||
| Common Shares | 60 | 35 | 11,756 | 9,797 | 9,797 |
| Retained earnings | -38,751 | -29,424 | -23,805 | -17,114 | -13,135 |
| Other shareholders' equity | 10,646 | 8,898 | -5,071 | -6,217 | -5,280 |
| TOTAL | $1,195 | $898 | $2,819 | $3,275 | $8,192 |
| Total Liabilities And Equity | $4,227 | $4,256 | $6,144 | $7,125 | $8,545 |